These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

61 related articles for article (PubMed ID: 14031845)

  • 1. Problems relating to investigational drugs.
    KELSEY FO
    Am J Pharm Sci Support Public Health; 1963 Mar; 135():93-7. PubMed ID: 14031845
    [No Abstract]   [Full Text] [Related]  

  • 2. Problems relating to investigational drugs.
    KELSEY FO
    J New Drugs; 1963; 3():71-4. PubMed ID: 14031846
    [No Abstract]   [Full Text] [Related]  

  • 3. Investigational drugs.
    Latiolais CJ; Visconti JA
    Am J Hosp Pharm; 1971 Dec; 28(12):980-4. PubMed ID: 5135195
    [No Abstract]   [Full Text] [Related]  

  • 4. Investigational drugs. I. By number.
    Latiolais CJ; Miller W
    Am J Hosp Pharm; 1967 Sep; 24(9):526-31. PubMed ID: 6049814
    [No Abstract]   [Full Text] [Related]  

  • 5. Investigational drugs.
    Am J Hosp Pharm; 1968 Jun; 25(6):317-9. PubMed ID: 5656778
    [No Abstract]   [Full Text] [Related]  

  • 6. PMA report on investigational new drugs.
    J Fla Med Assoc; 1966 Jun; 53(6):519-22. PubMed ID: 5933305
    [No Abstract]   [Full Text] [Related]  

  • 7. What hospitals should know about investigational drugs; responsibilities of the hospital staff.
    KERLIKOWSKE AC; FRANCKE DE
    Hospitals; 1958 Jan; 32(1):45-7. PubMed ID: 13491016
    [No Abstract]   [Full Text] [Related]  

  • 8. What hospitals should know about investigational drugs; guiding principles in medical research involving humans.
    SESSOMS SM
    Hospitals; 1958 Jan; 32(1):44 passim. PubMed ID: 13491015
    [No Abstract]   [Full Text] [Related]  

  • 9. Early access to new medicines.
    Breckenridge A; Walley T
    Clin Pharmacol Ther; 2008 Jul; 84(1):23-5. PubMed ID: 18288079
    [No Abstract]   [Full Text] [Related]  

  • 10. Productivity counts--but the definition is key.
    Mervis J
    Science; 2005 Jul; 309(5735):726. PubMed ID: 16051784
    [No Abstract]   [Full Text] [Related]  

  • 11. NME digest.
    Drug News Perspect; 2007; 20(6):395-402. PubMed ID: 18019747
    [No Abstract]   [Full Text] [Related]  

  • 12. [New drugs in Spain -- when are they to be considered cost-effective alternatives and profitable investments for the National Health System? ].
    Soto Alvarez J
    Farm Hosp; 2004; 28(4):299-304. PubMed ID: 15369442
    [No Abstract]   [Full Text] [Related]  

  • 13. Recent disclosures of clinical drug candidates.
    Armer R; Warne P; Witherington J
    Drug News Perspect; 2006; 19(1):65-72. PubMed ID: 16550257
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharma's year of trouble and strife.
    Frantz S
    Nat Rev Drug Discov; 2006 Jan; 5(1):7-9. PubMed ID: 16485339
    [No Abstract]   [Full Text] [Related]  

  • 15. Problems in coloring drugs with artificial coloring agents.
    HANNIG E
    Pharmazie; 1958 Oct; 13(10):628-31. PubMed ID: 13613964
    [No Abstract]   [Full Text] [Related]  

  • 16. A new miracle drug in the Caucasus?
    Lampert FH
    Med Pediatr Oncol; 2003 Nov; 41(5):452-3. PubMed ID: 14515386
    [No Abstract]   [Full Text] [Related]  

  • 17. Healthy scepticism.
    Mansfield PR
    Aust Fam Physician; 2003 Oct; 32(10):777. PubMed ID: 14596068
    [No Abstract]   [Full Text] [Related]  

  • 18. [The new list of doping preparations causes problems for physicians. Common drugs, for example cortisone, now classified as doping preparations].
    Eriksson BO; Nyberg H; Persson PM
    Lakartidningen; 2004 Jun; 101(23):2000-1. PubMed ID: 15232836
    [No Abstract]   [Full Text] [Related]  

  • 19. Public-private partnerships: new ways to discover, develop and deliver drugs for tropical diseases.
    Hentschel CC
    Southeast Asian J Trop Med Public Health; 2004; 35 Suppl 2():1-4. PubMed ID: 15906625
    [No Abstract]   [Full Text] [Related]  

  • 20. [Problems in pharmaceutical preparations of acute poisoning antagonist--consideration from result of a questionnaire survey about pharmaceutical preparations].
    Hara C; Hashizume T; Tanaka J; Kirimitsu M; Onaka A; Kishimoto M; Matsuzaka M; Toma M; Shiono S; Tafuse H; Oishi M; Kurokawa N
    Chudoku Kenkyu; 2006 Jan; 19(1):57-9. PubMed ID: 16491883
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.